ArticleFrontiers in immunology2022

Cuproptosis status affects treatment options about immunotherapy and targeted therapy for patients with kidney renal clear cell carcinoma.

Ganghua Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.